ADP-520

N/A

Report date: 2024/01/24 16:55:38

Base Information

Drug NameADP-520
Drug Alias NameADP-520
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionCD70 antigen modulators
TargetsCD70 antigen
Therapy Area/IndicationsHematologic NeoplasmsCarcinoma, Renal CellLymphoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdaptimmune Llc
China Registration ClassN/A

Develop Information

Active CompaniesAdaptimmune Llc
Inactive CompaniesN/A
Active IndicationsHematologic NeoplasmsCarcinoma, Renal CellLymphoma +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A